Novartis AG is 77.8x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($283.13 B vs $3.64 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACAD | NVS |
|---|---|---|
| Market cap | $3.64 B | $283.13 B |
| US-listed rank | #1650 | #47 |
| Revenue (latest FY) | $1.07B | - |
| Net income (latest FY) | $391.00M | - |
| Net margin | 36.5% | - |
| P/E (trailing FY) | 9.3 | - |
| SEC filings | 1,357 | 947 |
Novartis AG is 77.8x more valuable than ACADIA PHARMACEUTICALS INC by market capitalization ($283.13 B vs $3.64 B).
Full pages: ACADIA PHARMACEUTICALS INC and Novartis AG, or browse the full rankings.